Societal CDMO Inc (DELISTED) (SCTL:DL)
1.10
0.00 (0.00%)
USD |
NASDAQ |
Apr 08, 16:00
Societal CDMO Research and Development Expense (TTM)
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| December 31, 2018 | 4.402M |
| September 30, 2018 | 10.28M |
| June 30, 2018 | 8.223M |
| March 31, 2018 | 5.139M |
| December 31, 2017 | 4.46M |
| September 30, 2017 | 34.24M |
| June 30, 2017 | 31.98M |
| March 31, 2017 | 33.23M |
| December 31, 2016 | 33.28M |
| September 30, 2016 | 28.20M |
| June 30, 2016 | 23.86M |
| March 31, 2016 | 18.37M |
| Date | Value |
|---|---|
| December 31, 2015 | 12.31M |
| September 30, 2015 | 9.546M |
| June 30, 2015 | 10.46M |
| March 31, 2015 | 9.48M |
| December 31, 2014 | 7.953M |
| September 30, 2014 | 5.760M |
| June 30, 2014 | 2.248M |
| March 31, 2014 | 0.6566M |
| December 31, 2013 | 0.5435M |
| September 30, 2013 | 0.5179M |
| June 30, 2013 | 0.4725M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| XOMA Corp | 0.122M |
| Ironwood Pharmaceuticals Inc | 129.05M |
| CymaBay Therapeutics Inc (DELISTED) | 80.80M |
| Homology Medicines Inc (DELISTED) | 62.00M |
| Amgen Inc | 5.069B |